New Horizon Health Limited
HKEX:6606.HK
14.14 (HKD) • At close July 23, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) HKD.
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
| Revenue
| 764.96 | 212.761 | 70.567 | 58.275 | 18.816 |
| Cost of Revenue
| 118.79 | 58.116 | 33.318 | 23.957 | 14.976 |
| Gross Profit
| 646.17 | 154.645 | 37.249 | 34.318 | 3.84 |
| Gross Profit Ratio
| 0.845 | 0.727 | 0.528 | 0.589 | 0.204 |
| Reseach & Development Expenses
| 94.6 | 58.903 | 25.335 | 26.371 | 14.779 |
| General & Administrative Expenses
| 159.593 | 128.527 | 103.85 | 14.349 | 13.833 |
| Selling & Marketing Expenses
| 555.08 | 271.378 | 65.123 | 75.609 | 25.959 |
| SG&A
| 714.673 | 399.905 | 168.973 | 89.958 | 39.792 |
| Other Expenses
| -3.49 | -6.125 | -5.202 | 36.049 | -143.541 |
| Operating Expenses
| 805.783 | 452.683 | 189.106 | 152.378 | 86.46 |
| Operating Income
| -54.227 | -3,064.632 | -765.459 | -102.628 | -82.62 |
| Operating Income Ratio
| -0.071 | -14.404 | -10.847 | -1.761 | -4.391 |
| Total Other Income Expenses Net
| -25.431 | -20.704 | -22.962 | -3.607 | -142.249 |
| Income Before Tax
| -79.658 | -3,085.336 | -788.421 | -106.235 | -224.869 |
| Income Before Tax Ratio
| -0.104 | -14.501 | -11.173 | -1.823 | -11.951 |
| Income Tax Expense
| 0.655 | 20.704 | 0.303 | 0.23 | -141.791 |
| Net Income
| -80.313 | -3,106.04 | -788.724 | -106.465 | -224.869 |
| Net Income Ratio
| -0.105 | -14.599 | -11.177 | -1.827 | -11.951 |
| EPS
| -0.19 | -8.21 | -1.89 | -0.25 | -0.54 |
| EPS Diluted
| -0.19 | -8.21 | -1.89 | -0.25 | -0.54 |
| EBITDA
| -27.901 | -3,045.358 | -750.585 | -89.25 | -212.545 |
| EBITDA Ratio
| -0.036 | -14.314 | -10.636 | -1.532 | -11.296 |